Latigo Biotherapeutics, Inc. (LTGO)
21.08
-1.47
(-6.52%)
USD |
NASDAQ |
Sep 21, 16:00
20.70
-0.38
(-1.80%)
After-Hours: 20:00
Latigo Biotherapeutics EPS Diluted (Quarterly) : -0.3891 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3891 |
| March 31, 2026 | -0.3631 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4085 |
| March 31, 2025 | -0.3313 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.80M |
| Total Expenses (Quarterly) | 25.80M |
| Enterprise Value | 1.760B |
| Earnings Yield | -7.08% |
| Normalized Earnings Yield | -7.032 |